Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach
出版年份 2018 全文链接
标题
Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach
作者
关键词
Aspirin, Cardiovascular disease, Primary prevention, Secondary prevention, Gastrointestinal bleeding, Cardiovascular risk reduction
出版物
Current Atherosclerosis Reports
Volume 20, Issue 3, Pages -
出版商
Springer Nature
发表日期
2018-02-21
DOI
10.1007/s11883-018-0717-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Stuart J Connolly et al. LANCET
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Sonia S Anand et al. LANCET
- Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians’ Health Study
- (2017) Mary K. Downer et al. EUROPEAN UROLOGY
- Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review
- (2017) Riley Batchelor et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
- (2017) Serena Fasano et al. JOURNAL OF RHEUMATOLOGY
- Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus
- (2017) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Primary Prevention of Cardiovascular Disease in Diabetes Mellitus
- (2017) Jonathan D. Newman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study
- (2017) Linxin Li et al. LANCET
- Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial
- (2017) Francis K L Chan et al. LANCET
- Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review
- (2017) S Fasano et al. LUPUS
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triple Therapy for Atrial Fibrillation after PCI
- (2017) Jonathan P. Piccini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
- (2017) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection
- (2017) Raseen Tariq et al. JAMA Internal Medicine
- Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force
- (2016) Jessica Chubak et al. ANNALS OF INTERNAL MEDICINE
- Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force
- (2016) Evelyn P. Whitlock et al. ANNALS OF INTERNAL MEDICINE
- Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2016) Kirsten Bibbins-Domingo et al. ANNALS OF INTERNAL MEDICINE
- Aspirin and cardiovascular primary prevention in non-endstage chronic kidney disease: A meta-analysis
- (2016) Rupert W. Major et al. ATHEROSCLEROSIS
- Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes MellitusClinical Perspective
- (2016) Yoshihiko Saito et al. CIRCULATION
- Aspirin for the Primary Prevention of Cardiovascular Disease: In Need of Clarity
- (2016) Michael D. Miedema et al. Current Atherosclerosis Reports
- Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials
- (2016) S. K. Kunutsor et al. DIABETIC MEDICINE
- Efficacy of aspirin (325 mg) + omeprazole (40 mg) in treating coronary artery disease
- (2016) Tushar Sharma et al. EXPERT OPINION ON PHARMACOTHERAPY
- Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease
- (2016) Samia Mora et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy
- (2016) Muthiah Vaduganathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Stopping vs. Continuing Aspirin before Coronary Artery Surgery
- (2016) Paul S. Myles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
- (2016) Steven E. Nissen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk
- (2016) Peter C. Elwood et al. PLoS One
- Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study
- (2016) Michele Iudici et al. RHEUMATOLOGY
- Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors
- (2016) Shinichiro Uchiyama et al. STROKE
- Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease
- (2016) Samia Mora et al. JAMA Internal Medicine
- Association of Proton Pump Inhibitors With Risk of Dementia
- (2016) Willy Gomm et al. JAMA Neurology
- The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease
- (2016) Abigail Johnston et al. Current Cardiology Reports
- Cardiovascular Complications of HIV in Endemic Countries
- (2016) Matthew J. Feinstein et al. Current Cardiology Reports
- Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer
- (2016) Yin Cao et al. JAMA Oncology
- Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
- (2016) Luis A. García Rodríguez et al. PLoS One
- Estimates of Global and Regional Premature Cardiovascular Mortality in 2025
- (2015) Gregory A. Roth et al. CIRCULATION
- Should patients stop taking aspirin for primary prevention?
- (2015) J. P. DEPTA et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis
- (2015) A. Tran-Duy et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes
- (2015) Thomas G Weiser et al. LANCET
- Myocardial Injury after Noncardiac Surgery
- (2014) Fernando Botto et al. ANESTHESIOLOGY
- 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
- (2014) EUROPEAN HEART JOURNAL
- Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors
- (2014) Yasuo Ikeda et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
- (2014) Lee A. Fleisher et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Aspirin in Patients Undergoing Noncardiac Surgery
- (2014) P.J. Devereaux et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
- (2013) Daniel E. Singer ANNALS OF INTERNAL MEDICINE
- Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery
- (2013) P.J. Devereaux ANNALS OF INTERNAL MEDICINE
- Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial
- (2013) Nancy R. Cook et al. ANNALS OF INTERNAL MEDICINE
- Vascular Protection in People with Diabetes
- (2013) James A. Stone et al. Canadian Journal of Diabetes
- Effect of Low-Dose Aspirin on Primary Prevention of Cardiovascular Events in Japanese Diabetic Patients at High Risk
- (2013) Sadanori Okada et al. CIRCULATION JOURNAL
- The State of US Health, 1990-2010
- (2013) Christopher J. L. Murray JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review
- (2013) Sara R. Schoenfeld et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Cardiovascular Disease and HIV Infection
- (2013) Virginia A. Triant Current HIV/AIDS Reports
- Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy
- (2012) Samia Mora et al. CIRCULATION
- Drug Resistance and Pseudoresistance
- (2012) Tilo Grosser et al. CIRCULATION
- Aspirin Resistance: Current Status and Role of Tailored Therapy
- (2012) Jonathan Grinstein et al. CLINICAL CARDIOLOGY
- Underutilization of Aspirin for Primary Prevention of Cardiovascular Disease Among HIV-Infected Patients
- (2012) G. A. Burkholder et al. CLINICAL INFECTIOUS DISEASES
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary
- (2011) et al. CIRCULATION
- Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update
- (2011) Lori Mosca et al. CIRCULATION
- Novel Lipid Mediators Promote Resolution of Acute Inflammation
- (2010) Matthew Spite et al. CIRCULATION RESEARCH
- Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial IndexA Randomized Controlled Trial
- (2010) F. Gerald R. Fowkes JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular disease and HIV infection: host, virus, or drugs?
- (2008) Esteban Martínez et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial
- (2008) Hisao Ogawa JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
- (2008) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- An estimation of the global volume of surgery: a modelling strategy based on available data
- (2008) Thomas G Weiser et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now